173 related articles for article (PubMed ID: 26975597)
1. The Third Policy Arena: Standard-Setting Organizations.
Consult Pharm; 2016 Mar; 31(3):176. PubMed ID: 26975597
[No Abstract] [Full Text] [Related]
2. USP general chapter <797> pharmaceutical compounding-sterile preparations.
Hung JC
J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
[No Abstract] [Full Text] [Related]
3. GMPs vs GCPs: United States Pharmacopeia General Chapters.
Allen LV
Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791
[No Abstract] [Full Text] [Related]
4. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
Hung JC
J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
[No Abstract] [Full Text] [Related]
5. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
Kastango ES
JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
[TBL] [Abstract][Full Text] [Related]
6. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
Hyde TD
Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
[TBL] [Abstract][Full Text] [Related]
7. PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives.
Allen LV
Int J Pharm Compd; 2017; 21(3):180. PubMed ID: 28557778
[No Abstract] [Full Text] [Related]
8. USP publishes enforceable chapter on sterile compounding.
Thompson CA
Am J Health Syst Pharm; 2003 Sep; 60(18):1814, 1817-8, 1822. PubMed ID: 14521028
[No Abstract] [Full Text] [Related]
9. Report on the PQRI impurity characterization and quantification best practices survey.
Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
[No Abstract] [Full Text] [Related]
10. Joint Commission expectations related to USP-NF Chapter 797 on compounding sterile preparations.
Jt Comm Perspect; 2006 Apr; 26(4):5. PubMed ID: 16786622
[No Abstract] [Full Text] [Related]
11. Compounding pharmacies: before and after an inspection.
Kulkarni D; Ricketts S
Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
[TBL] [Abstract][Full Text] [Related]
12. Implementing United States Pharmacopeia Chapter <1163>. Quality assurance in pharmaceutical compounding, Part 3: Testing.
Allen LV
Int J Pharm Compd; 2012; 16(4):322-8. PubMed ID: 23050393
[TBL] [Abstract][Full Text] [Related]
13. 2013 State Compounding Legislation Tracker.
Miller DG
Int J Pharm Compd; 2013; 17(5):375-8. PubMed ID: 24459782
[No Abstract] [Full Text] [Related]
14. GMPs vs GCPs: manufacturing and compounding definitions.
Allen LV
Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778
[No Abstract] [Full Text] [Related]
15. Exemption of radiopharmaceuticals from <797>.
Hung JC; VanBrocklin HF
J Nucl Med; 2004 Oct; 45(10):14N. PubMed ID: 15551510
[No Abstract] [Full Text] [Related]
16. Basics of compounding: repackaging, part 2.
Allen LV
Int J Pharm Compd; 2013; 17(2):136-40. PubMed ID: 23696175
[TBL] [Abstract][Full Text] [Related]
17. USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy.
Kastango ES; Bradshaw BD
Am J Health Syst Pharm; 2004 Sep; 61(18):1928-38. PubMed ID: 15487884
[No Abstract] [Full Text] [Related]
18. From the SNM Committee on Pharmacopeia: Exemption of radiopharmaceuticals from <797>.
Hung JC;
J Nucl Med; 2004 Oct; 45(10):13N, 16N. PubMed ID: 15551509
[No Abstract] [Full Text] [Related]
19. Does your pharmacy have a compounding isolator?
LaBella CJ
Am J Health Syst Pharm; 2007 Apr; 64(8):855-8. PubMed ID: 17420203
[No Abstract] [Full Text] [Related]
20. Quality control analytical methods: strategies to ensure a robust quality-control microbiology program.
Griffiths T; Connors A
Int J Pharm Compd; 2013; 17(2):130-4. PubMed ID: 23696174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
